Homing Characteristics of Donor T Cells after Experimental Allogeneic Bone Marrow Transplantation and Posttransplantation Therapy for Multiple Myeloma

Slides:

Advertisements

Similar presentations

Homing Characteristics of Donor T Cells after Experimental Allogeneic Bone Marrow Transplantation and Posttransplantation Therapy for Multiple Myeloma

Advertisements

Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C

Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation Michael Weber,

William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D

Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.

Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,

Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation

Extracorporeal Photopheresis Attenuates Murine Graft-versus-Host Disease via Bone Marrow–Derived Interleukin-10 and Preserves Responses to Dendritic Cell.

Identification of Stem Cell Transcriptional Programs Normally Expressed in Embryonic and Neural Stem Cells in Alloreactive CD8+ T Cells Mediating Graft-versus-Host.

Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells

Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver Alina Schreder,

Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine Weiqing Jing,

Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J

Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation Jian-ming Li, John Gorechlad,

William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D

Following the Development of a CD4 T Cell Response In Vivo

Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone.

Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft- versus-Host Disease in a Murine Model of Allogeneic Hematopoietic.

Vaccination of Children following Allogeneic Stem Cell Transplantation

Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.

LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.

IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ–Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-Versus-Host.

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells by Elke Scandella, Ying Men, Silke Gillessen,

Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor–Alpha Production in Mice after.

Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or.

A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome Gerhard C. Hildebrandt, Krystyna.

Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.

PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model) Yehudith Azar, Reut.

Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation Yang Wang, Dan Li, Dan Jones, Roland.

Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients Takero Shindo, Takayuki.

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.

Volume 82, Issue 1, Pages (July 2012)

Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute.

Volume 18, Issue 5, Pages (May 2003)

Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens Hisaki Fujii,

Xinchun Chen, Yi Zeng, Gang Li, Nicolas Larmonier, Michael W

Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced- Intensity Conditioning Creates a Platform for Immunotherapy with Donor.

An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell Transplantation Wannee Asavaroengchai,

Survival and Function of MiHA Epitope-Specific Host CD8 TM Cells Following Ablative Conditioning and HCT Alwi M. Shatry, Derry C. Roopenian, Robert B.

Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients Wei He, Jeremy J. Racine, Heather F.

Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels Chien-Chun Steven.

The Pentostatin Plus Cyclophosphamide Nonmyeloablative Regimen Induces Durable Host T Cell Functional Deficits and Prevents Murine Marrow Allograft Rejection

Enrichment of IL-12–Producing Plasmacytoid Dendritic Cells in Donor Bone Marrow Grafts Enhances Graft-versus-Leukemia Activity in Allogeneic Hematopoietic.

Volume 73, Issue 1, Pages (January 2008)

Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.

Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,

Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation Isabel Barao, Maite.

T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.

Volume 7, Issue 4, Pages (October 2016)

Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation Jeffery J. Auletta,

Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune Response Andrea T. Badillo, Kirstin J. Beggs, Elisabeth.

Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells

Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease Isao Tawara,

Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells

Volume 37, Issue 5, Pages (November 2012)

A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.

Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice Dapeng Wang, Yu Yu, Kelley Haarberg,

A CD4 Domain 1 CC′ Loop Peptide Analogue Enhances Engraftment in a Murine Model of Bone Marrow Transplantation with Sublethal Conditioning Gabor Varadi,

Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation

Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.

In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.

B7.2−/− Mature Dendritic Cells Generate T-Helper 2 and Regulatory T Donor Cells in Fetal Mice after In Utero Allogeneic Bone Marrow Transplantation Swati.

Volume 19, Issue 3, Pages (September 2003)

CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease Philip R Streeter,

Volume 38, Issue 3, Pages (March 2013)

Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation Jian-Ming Li, Edmund K.

Early Vaccination with Tumor Lysate-Pulsed Dendritic Cells after Allogeneic Bone Marrow Transplantation Has Antitumor Effects Jeffrey S. Moyer, Gabriel.

Volume 28, Issue 5, Pages (May 2008)

Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.

Volume 25, Issue 6, Pages (June 2017)

Presentation transcript:

Homing Characteristics of Donor T Cells after Experimental Allogeneic Bone Marrow Transplantation and Posttransplantation Therapy for Multiple Myeloma Robbert van der Voort, Thomas J.H. Volman, Viviènne Verweij, Peter C.M. Linssen, Frans Maas, Konnie M. Hebeda, Harry Dolstra Biology of Blood and Marrow Transplantation Volume 19, Issue 3, Pages 378-386 (March 2013) DOI: 10.1016/j.bbmt.2012.12.014 Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 DLI and miHA-loaded DC vaccination induce superior GVM responses. (A) Scheme showing the treatment schedule of this allo-SCT mouse model. C57BL/KaLwRij mice were irradiated twice and underwent allo-HCT with T cell-depleted BM of MHC-matched, miHA-mismatched C3.SW-H2b/SnJ (C3.SW) mice. After a repopulation period of 2 months, mice were vaccinated with unloaded DCs or with DCs loaded with miHA H7 peptide, and received a MM challenge and DLI the next day. The mice were then evaluated for the development of GVM and GVHD. (B) Kaplan-Meier curves showing the survival of mice treated with allo-SCT only (BMT), BMT plus MM, and BMT MM mice treated with DLI only or in combination with unloaded or H7-loaded DC vaccination. Data are the combined result of 2 similar experiments. Each group comprised 10-16 mice. Median survival times and P values <.05 are shown. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Increased infiltration of CD8+ effector T cells in the BM of allo-BMT recipient mice bearing MM. Shown are absolute numbers of BM cells (A) and BM T cells (B), and percentages of activated CD4+ BM T cell subsets (C) and CD8+ BM T cell subsets (D) of mice treated with allo-BMT (BMT) with or without MM, with or without DLI, and with or without H7+DC vaccination. T cell percentages were determined by flow cytometry. Effector/effector memory T cells (TEF/EM) and central memory T cells (TCM) were characterized as CD44hiCD62L- and CD44hiCD62L+, respectively. Data are the combined results of at least 3 analyses, with 4-13 mice analyzed per group. *P < .05; **P < .01; ***P < .001, compared with the BMT group. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 BM-infiltrating CD8+ T cells have a distinct effector homing phenotype. (A) CD4+ T cells and CD8+ T cells isolated from the BM of 4 experimental groups were assessed for the expression of a panel of homing receptors. Levels of receptors with a gradual expression pattern (CD44, PSGL-1, LFA-1 and α4β1) are presented as mean fluorescence intensity. The levels of homing receptors expressed on discrete T cell populations (CD62L, CXCR3, and CXCR6) are displayed as percentage of positive cells. Data are the combined results of at least 3 analyses. Groups comprised 4-9 mice. *P < .05; **P < .01; ***P < .001, compared to the BMT group. (B) CXCR3 mRNA levels in the BM (femurs and tibias) of the experimental groups, as determined by qPCR. Data are the combined result of 2 analyses, with 7-8 mice analyzed per group. P values <.05 are shown below the panels. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 MM growth and post-transplantation therapy strongly increase the expression of inflammatory chemokines and IFN-γ in the BM. (A) mRNA levels of the inflammatory chemokines CXCL9, CXCL10, CXCL11, and CXCL16 and the homeostatic chemokine CXCL12 in the BM (femurs and tibias) of the experimental groups. (B) Chemokine mRNA levels in ex vivo MM cells (n = 2) sorted from the BM of BMT MM mice. (C) mRNA expression levels of CXCL9 and CXCL16 protein in the experimental groups. (D) mRNA expression levels of proinflammatory cytokine IFN-γ in the experimental groups. mRNA levels were determined by qPCR; protein levels, by ELISA. Data are the combined results of at least 3 analyses, with 5-10 mice analyzed per group. P values <.05 are shown below each panel. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 IFN-γ and TNF-α induce the expression of inflammatory chemokines by BMECs. mRNA levels of the chemokines CXCL9, CXCL10, CXCL11, CXCL12, and CXCL16 in BMEC STR-12 were determined by qPCR. BMECs were cultured in the presence of the indicated concentrations of IFN-γ, TNF-α, or IFN-γ plus 10 ng/mL TNF-α for 2 days. Data are mean ± SD of duplicates. Results are representative of 2 experiments. AU, arbitrary units. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 BMECs present inflammatory chemokines on multiple HSPGs. (A) BMECs show high expression of heparan sulfate on staining with anti-heparan sulfate (bold line) versus isotype control (stippled line). (B) RT-PCR with a panel of HSPG-specific primers shows expression of 8 of 11 HSPGs by BMECs. (C) BMEC surface expression of syndecans-1, syndecans-4, and glypicans-1 (bold lines) versus isotype controls (stippled lines), as determined by flow cytometry. (D) BMECs were loaded with CXCL9 or CXCL10, washed, and analyzed by flow cytometry for the presence of the chemokines. (E) Expression of heparan sulfate (HS) and chondroitin sulfate (CS) with or without enzymatic treatment of BMECs (left). BMEC-bound CXCL9 and CXCL10 are released on the cleavage of heparan sulfate by heparinases, but not after removal of chondroitin sulfate (right). Relative expression is in delta mean fluorescence intensity (MFI) means MFI of the specific marker minus isotype control. One representative experiment out of 3 experiments is shown. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 7 BMEC-presented inflammatory chemokines induce transendothelial migration of effector T cells. (A) CD8+ effector T cells express high levels of CXCR3. Peptide-activated splenocytes from OT-1 mice were cultured for 7 days and then stained for CXCR3 (filled histogram) or isotype control (stippled line). (B) CD8+ effector T cells migrate in response to CXCL9 under shear-free conditions in Transwells. Data represent mean ± SD of duplicates. (C) Presentation of CXCL9 by BMECs induces transendothelial migration of CD8+ effector T cells. OT-1 effector T cells interacting with control BMECs or CXCL9-loaded BMECs during physiological sheer flow (2 dynes/cm2) were divided into 4 groups based on migratory phenotype: detachment, stationary arrest, locomotion, and transendothelial migration. Results are mean ± SEM of 4 experiments. *P = .02. Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure S1 Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure S2 Biology of Blood and Marrow Transplantation 2013 19, 378-386DOI: (10.1016/j.bbmt.2012.12.014) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions